Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM) Patients in India: A Real-World Perspective

被引：0
|
作者：
Singh, Vikram Jit
Singh, Manmohan
Patidar, Hemant
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1506-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1506-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Association of Treatment Persistence and Adherence With Real-World Outcomes Among Insulin-Treated Patients With Type 2 Diabetes Mellitus (T2DM)
    Wei, Wenhui
    Pan, Chunshen
    Xie, Lin
    Baser, Onur
    DIABETES, 2012, 61 : A4 - A4
  • [32] REAL-WORLD INCIDENCE OF HYPOGLYCEMIA AND ASSOCIATED COSTS AMONG INSULIN GLARGINE-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Xie, L.
    Wei, W.
    Pan, C.
    Baser, O.
    VALUE IN HEALTH, 2012, 15 (07) : A493 - A493
  • [33] Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
    Pennisi, Grazia
    Enea, Marco
    Falco, Vincenzo
    Aithal, Guruprasad P.
    Palaniyappan, Naaventhan
    Yilmaz, Yusuf
    Boursier, Jerome
    Cassinotto, Christophe
    de Ledinghen, Victor
    Chan, Wah Kheong
    Mahadeva, Sanjiv
    Eddowes, Peter
    Newsome, Philip
    Karlas, Thomas
    Wiegand, Johannes
    Wong, Vincent Wai-Sun
    Schattenberg, Joern M.
    Labenz, Christian
    Kim, Won
    Lee, Myoung Seok
    Lupsor-Platon, Monica
    Cobbold, Jeremy F. L.
    Fan, Jian-Gao
    Shen, Feng
    Staufer, Katharina
    Trauner, Michael
    Stauber, Rudolf
    Nakajima, Atsushi
    Yoneda, Masato
    Bugianesi, Elisabetta
    Younes, Ramy
    Gaia, Silvia
    Zheng, Ming-Hua
    Camma, Calogero
    Anstee, Quentin M.
    Mozes, Ferenc E.
    Pavlides, Michael
    Petta, Salvatore
    HEPATOLOGY, 2023, 78 (01) : 195 - 211
  • [34] Impact of Diabetes Treatment-Related Attributes on Costs of Type 2 Diabetes (T2DM) Patients in a Real-World Population
    Lee, Yi-Chien
    Meng, Jie
    Casciano, Roman
    Perrin, Allison
    Gultyaev, Dmitry
    Tong, Liyue
    Kitio-Dschassi, Brice
    DIABETES, 2016, 65 : A323 - A323
  • [35] Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the Eastern region of India
    Sinha, Anirban
    Bankura, Biswabandhu
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2023, 12
  • [36] The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    Dai, Chia-Yen
    Fang, Tzu-Jung
    Hung, Wei-Wen
    Tsai, Hui-Ju
    Tsai, Yi-Chun
    BIOMEDICINES, 2022, 10 (07)
  • [37] Role of type 2 diabetes mellitus in nonalcoholic fatty liver disease
    Filik, L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (12) : 1367 - 1367
  • [38] The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    Kosmalski, Marcin
    Ziolkowska, Sylwia
    Czarny, Piotr
    Szemraj, Janusz
    Pietras, Tadeusz
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [39] Remogliflozin in Indian T2DM Patients: A Real-World Study
    Bhattacharya, Supratik
    Katare, Sagar
    DIABETES, 2020, 69
  • [40] Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study
    Zhang, Zhi-Hui
    Ke, Jiang-Feng
    Lu, Jun-Xi
    Liu, Yun
    Wang, Ai-Ping
    Li, Lian-Xi
    DIABETES & METABOLISM JOURNAL, 2022, 46 (01) : 129 - 139
12345